Registry of the German CLL Study Group

Inclusion Criteria8

• Confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK-LGL, HCL or Richter's transformation
• years of age or older
• Signed, written informed consent
• Presence of one or more of the following disease situations:
• Newly diagnosed patients without treatment indication (eligible for watch and wait Approach Treatment within a clinical trial according to the AMG or status post participation in a clinical Trial)
• Treatment with standard therapies approved for the eligible entities or status post treatment (outside of clinical trials)
• Referral for evaluation the indication for HSCT
• Relapsed disease status (even if first diagnosis was prior to activation of the registry)